Atlas Trials

Proof-of-concept Trial of IVA337 in Diffuse Cutaneous Systemic Sclerosis

Clinical trial NCT02503644 · COMPLETED

Trial details

NCT number
NCT02503644
Sponsor
Inventiva Pharma
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Scleroderma, DiffuseDiffuse Cutaneous Systemic Sclerosis
Start date
2015-10-29
Primary completion
2018-10-01
Enrollment
145

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.